NCT03149172

Brief Summary

The purpose of this pilot study is to conduct a interventional prospective clinical trial to evaluate the efficacy of three different xenografts for ridge preservation by comparing the quality of newly formed bone using histomorphometric and micro CT analysis.The three xenograft materials under investigation are Bio-Oss® (bovine derived xenograft), Equimatrix® (equine derived xenograft), and Endobon® (bovine derived xenograft). There are no prospective studies comparing the effectiveness of these three materials, Bio-Oss®, Endobon® and Equimatrix®, when placed in extraction sockets. Participants will be recruited from patients in the TUSDM clinics that require extraction of single rooted non-molar tooth and are treatment planned to receive dental implants in the future. Participants will be randomized to receive one of the three xenograft materials after tooth extraction. The percentage of newly formed bone and bone density will be compared between the three materials 4-6 months after ridge preservation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 20, 2014

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 9, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 11, 2017

Completed
3.4 years until next milestone

Results Posted

Study results publicly available

September 25, 2020

Completed
Last Updated

September 25, 2020

Status Verified

September 1, 2020

Enrollment Period

1.6 years

First QC Date

May 9, 2017

Results QC Date

August 11, 2020

Last Update Submit

September 1, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percent New Bone Formation

    Histomorphometric determination of % new bone formation

    4-6 months after ridge preservation surgery

Secondary Outcomes (1)

  • Bone Density

    4-6 months after ridge preservation surgery

Study Arms (3)

Equimatrix®

EXPERIMENTAL

Equimatrix® + Mucograft or alternatives

Device: Equimatrix®

Bio-Oss®

EXPERIMENTAL

Bio-Oss® + Mucograft or alternatives

Device: Bio-Oss®

Endobon®

EXPERIMENTAL

Endobon® + Mucograft or alternatives

Device: Endobon®

Interventions

Ridge preservation bone grafting after tooth extraction

Equimatrix®
Bio-Oss®DEVICE

Ridge preservation bone grafting after tooth extraction

Bio-Oss®
Endobon®DEVICE

Ridge preservation bone grafting after tooth extraction

Endobon®

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Non-restorable single rooted tooth in anterior or premolar region
  • Patient previously treatment planned for implant procedure and implant restoration.
  • \> 10 mm from maxillary sinus or inferior alveolar canal (IAC)
  • Intact buccal bone (only minor dehiscence or fenestrations (approximately \< 50% of socket depth) can be accepted
  • Non-smokers.
  • Patients treatment planned for extraction and ridge preservation at Tufts University School of Dental Medicine.

You may not qualify if:

  • Poor oral hygiene (plaque index\>30%).
  • Systemic diseases that affect bone metabolism:
  • i. Osteoporosis ii. Osteomalacia iii. Hyperthyroidism iv. Hyperparathyroidism v. Paget's disease
  • Inflammatory and autoimmune diseases of the oral cavity (severe bone loss) (self-report):
  • i. Severe chronic periodontitis ii. Aggressive periodontitis iii. Necrotizing ulcerative periodontitis iv. Crohn's disease v. Multiple sclerosis vi. Rheumatoid arthritis vii. Systemic lupus erythematosus
  • History of radiation to the head and neck, and /or chemotherapy.
  • Current corticosteroid therapy.
  • History of IV Bisphosphonates therapy or \>3 years of oral intake.
  • Infectious diseases such as HIV, tuberculosis, Hepatitis (self-report).
  • Known allergy to research related materials.
  • Self-reported pregnancy or lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tufts University School of Dental Medicine

Boston, Massachusetts, 02111, United States

Location

MeSH Terms

Conditions

Alveolar Bone Loss

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Results Point of Contact

Title
Dr. Yong Hur
Organization
Tufts University

Study Officials

  • Yong Hur, DDS, DMD, MS

    Tufts University School of Dental Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The surgeon and the subject will not be blinded. The evaluation of the core histology will be done by a blinded investigator.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 9, 2017

First Posted

May 11, 2017

Study Start

October 20, 2014

Primary Completion

June 7, 2016

Study Completion

December 7, 2016

Last Updated

September 25, 2020

Results First Posted

September 25, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations